Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia
 
Creator Kieh, Mark W. Browne, Sarah M. Grandits, Greg A. Blie, Julie Doe-Anderson, Jestina W. Hoover, Marie L. Davis, Bionca Reilly, Cavan S. Neaton, James D. Lane, H. Clifford Kennedy, Stephen B.
 
Subject — reference ranges; Liberia; chemistries; haematology; paediatric
Description Background: As more research is conducted in Liberia, there is a need for laboratory reference limits for common chemistry and haematology values based on a healthy population. Reference limits from the United States may not be applicable.Objective: The aim of this study was to present laboratory reference ranges from a Liberian population and compare them to United States ranges.Methods: Serum chemistry and haematology values from 2529 adults and 694 children and adolescents obtained from two studies conducted in Liberia between 2015 to 2017 were used to determine reference limits. After removing outliers, the reference limits defined by the 2.5th and 97.5th percentiles were determined by sex in three age groups (6–11, 12–17, and 18+ years).Results: The median (interquartile range) of adults was 29 (23, 37) years; 44% were female. The median (interquartile range) for children and adolescents was 12 (9, 15) years; 53% were female. Several reference ranges determined using Liberian participants differed from those in the US. For chemistries, a high percentage of both adults and children/adolescents had high serum chloride levels based on United States ranges. For haematology, a high percentage of Liberian participants had haemoglobin and related assays below the lower limit of United States ranges.Conclusion: Chemistry and haematology reference intervals determined for a Liberian population of healthy individuals should be considered for establishing eligibility criteria and monitoring of laboratory adverse events for clinical trials as well as for use in clinical settings in Liberia and perhaps for other countries in Western Africa.
 
Publisher AOSIS
 
Contributor
Date 2020-11-25
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v9i1.1080
 
Source African Journal of Laboratory Medicine; Vol 9, No 1 (2020); 8 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/1080/1738 https://ajlmonline.org/index.php/ajlm/article/view/1080/1737 https://ajlmonline.org/index.php/ajlm/article/view/1080/1739 https://ajlmonline.org/index.php/ajlm/article/view/1080/1736
 
Coverage — — —
Rights Copyright (c) 2020 Mark W. Kieh, Sarah M. Browne, Greg A. Grandits, Julie Blie, Jestina W. Doe-Anderson, Marie L. Hoover, Bionca Davis, Cavan S. Reilly, James D. Neaton, H. Clifford Lane, Stephen B. Kennedy https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT